GlassScriptPhysician profile
Aanchal Taneja
NPI 1174725667
$168,595.46
in general payments reported to CMS, 2019-2025
45 companies · $23K in 2025
The $23K reported for 2025 was more than what 93% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $20K · 2021: $15K · 2022: $51K · 2023: $2,157 · 2024: $13K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $26K · Food and Beverage: $5,648 · Travel and Lodging: $4,519 · Education: $1,874 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $26,329.00 |
| Food and Beverage | $5,648.39 |
| Travel and Lodging | $4,519.40 |
| Education | $1,873.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $129,868.39 | 2019-2025 | Crexont, Ongentys, Ongentys 50mg Capsules 30 |
| Neurocrine Biosciences, INC. | $15,971.41 | 2019-2025 | Ingrezza, Ongentys |
| Mdd US Operations, LLC | $8,782.39 | 2019-2025 | Gocovri, Gocovri, Apokyn |
| Sunovion Pharmaceuticals INC. | $3,337.49 | 2020-2022 | |
| Abbvie INC. | $1,420.97 | 2019-2025 | Qulipta, Ubrelvy, Duopa |
| Acadia Pharmaceuticals INC | $1,411.21 | 2019-2025 | Nuplazid |
| Livanova USA, INC. | $1,184.98 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Teva Pharmaceuticals USA, INC. | $1,070.53 | 2019-2025 | Austedo Xr, Austedo Xr |
| Boston Scientific Corporation | $811.96 | 2019-2025 | Vercise, General - Dbs |
| Abbott Laboratories | $545.19 | 2020-2025 | Infinity |
| Acorda Therapeutics, INC | $364.99 | 2019-2023 | Inbrija, Ampyra |
| Merz Pharmaceuticals, LLC | $337.99 | 2023-2025 | Xeomin |
| Eisai INC. | $287.37 | 2023-2025 | |
| Kyowa Kirin, INC. | $252.43 | 2020-2023 | Nourianz |
| Lilly USA, LLC | $245.03 | 2024-2025 | Kisunla, Amyvid |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $242.04 | 2019-2020 | |
| Allergan, INC. | $231.38 | 2020-2022 | |
| Lundbeck LLC | $220.12 | 2019-2025 | Vyepti |
| Medtronic, INC. | $205.91 | 2021-2024 | Percept PC Brainsense, Activa PC |
| Ipsen Biopharmaceuticals, INC | $180.38 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $151.98 | 2019-2021 | |
| Avion Pharmaceuticals | $151.03 | 2021-2023 | Dhivy |
| Arbor Pharmaceuticals, INC. | $128.24 | 2019-2022 | |
| Ucb, INC. | $124.86 | 2019-2024 | Rystiggo |
| Sk Life Science, INC. | $118.73 | 2020-2023 | |
| Amgen INC. | $117.70 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $107.34 | 2020-2022 | |
| Pfizer INC. | $101.31 | 2023-2024 | |
| Insightec,INC | $60.73 | 2024 | Exablate |
| Biogen, INC. | $60.47 | 2021-2024 | Skyclarys |
| Azurity Pharmaceuticals, INC. | $54.74 | 2023-2024 | Horizant, Horizant |
| Biohaven Pharmaceuticals, INC. | $51.95 | 2020-2021 | |
| Catalyst Pharmaceuticals, INC. | $45.50 | 2020-2021 | |
| Argenx US, INC. | $44.67 | 2023 | Vyvgart |
| Vertical Pharmaceuticals, LLC | $44.37 | 2019 | |
| Revance Therapeutics, INC. | $38.49 | 2024 | Daxxify |
| Ge Healthcare | $34.31 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.66 | 2022 | |
| Horizon Therapeutics Plc | $31.04 | 2022 | |
| Currax Pharmaceuticals LLC | $29.07 | 2022-2024 | Onzetra Xsail |
| Averitas Pharma INC. | $26.03 | 2024 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $23.07 | 2023 | |
| Supernus Pharmaceuticals, INC. | $16.47 | 2019 | |
| Endo Pharmaceuticals INC. | $15.72 | 2019 | |
| Merz North America, INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aanchal Taneja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.